Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 292.00
Bid: 297.00
Ask: 309.00
Change: -8.00 (-2.67%)
Spread: 12.00 (4.04%)
Open: 297.00
High: 297.00
Low: 292.00
Prev. Close: 300.00
APTD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directors Shareholdings

21 Mar 2013 15:33

RNS Number : 5892A
Microgen PLC
21 March 2013
 



NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS

On 21 March 2013 David Sherriff, Chief Executive Officer of Microgen plc, and Philip Wood, Group Finance Director of Microgen plc, increased their respective shareholdings to 438,466 (previously 189,000 shares) and 142,246 (previously 60,000 shares) respectively.

 

The increase in both Mr Sherriff and Mr Wood’s shareholding is as a result of the exercise of a total of 927,561 share options with a total of 595,849 shares sold to cover tax and other costs arising on the exercise of share options.  The following tables provide further details of the notification for Mr Sherriff and Mr Wood.

 

 

1.

Name of the issuer

2.

State whether the notification relates to (i) a transaction notified in accordance with DR 3.1.4R(1)(a); or

(ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as extended by section 328) of the Companies Act 1985; or

(iii) both (i) and (ii)

MICROGEN PLC

(iii) - both (i) and (ii)

3.

Name of person discharging managerial responsibilities/director

4.

State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

DAVID SHERRIFF

N/A

5.

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest

6.

Description of shares (including class), debentures or derivatives or financial instruments relating to shares

SEE 3 ABOVE

ORDINARY SHARES OF 5P EACH

7.

Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

8

State the nature of the transaction

DAVID SHERRIFF

EXERCISE OF SHARE OPTIONS AND PART SALE OF SHARES TO COVER EXERCISE COSTS AND TAX LIABILITY.

9.

Number of shares, debentures or financial instruments relating to shares acquired

10.

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

718,381 SHARES

0.87%

11.

Number of shares, debentures or financial instruments relating to shares disposed

12.

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

468,915 SHARES

 

 

0.57%

13.

Price per share or value of transaction

14.

Date and place of transaction

75,000 SHARES PURCHASED AT AN OPTION PRICE OF 42.5 PENCE.

100,000 SHARES PURCHASED AT AN OPTION PRICE OF 70.5 PENCE.

397,991 SHARES PURCHASED AT AN OPTION PRICE OF 5 PENCE.

93,340 SHARES PURCHASED AT AN OPTION PRICE OF 5 PENCE.

52,050 SHARES PURCHASED AT AN OPTION PRICE OF 5 PENCE.

468,915 SHARES SOLD AT A PRICE OF 118 PENCE.

21 MARCH 2013, UK

15.

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

16.

Date issuer informed of transaction

438,466 SHARES

0.53%

21 MARCH 2013

 

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes

17

Date of grant

18.

Period during which or date on which it can be exercised

N/A

N/A

19.

Total amount paid (if any) for grant of the option

20.

Description of shares or debentures involved (class and number)

N/A

N/A

21.

Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

22.

Total number of shares or debentures over which options held following notification

N/A

N/A

23.

Any additional information

24.

Name of contact and telephone number for queries

INFORMATION IS BASED ON THE COMPANY'S CURRENT ISSUED SHARE CAPITAL WHICH IS 82,527,244

ANJUM O'NEILL, COMPANY SECRETARY, MICROGEN PLC: 020 7496 8100

 

This form is intended for use by an issuer to make a RIS notification required by DR 3.1.4R(1).

 

1.

Name of the issuer

2.

State whether the notification relates to (i) a transaction notified in accordance with DR 3.1.4R(1)(a); or

(ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as extended by section 328) of the Companies Act 1985; or

(iii) both (i) and (ii)

MICROGEN PLC

(iii) - both (i) and (ii)

3.

Name of person discharging managerial responsibilities/director

4.

State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

PHILIP WOOD

N/A

5.

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest

6.

Description of shares (including class), debentures or derivatives or financial instruments relating to shares

SEE 3 ABOVE

ORDINARY SHARES OF 5P EACH

7.

Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

8

State the nature of the transaction

PHILIP WOOD

EXERCISE OF SHARE OPTIONS AND PART SALE OF SHARES TO COVER EXERCISE COSTS AND TAX LIABILITY.

9.

Number of shares, debentures or financial instruments relating to shares acquired

10.

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

209,180 SHARES

0.25%

11.

Number of shares, debentures or financial instruments relating to shares disposed

12.

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

126,934 SHARES

0.15%

13.

Price per share or value of transaction

14.

Date and place of transaction

93,340 SHARES PURCHASED AT AN OPTION PRICE OF 5 PENCE

70,005 SHARES PURCHASED AT AN OPTION PRICE OF 5 PENCE

45,835 SHARES PURCHASED AT AN OPTION PRICE OF 5 PENCE

126,934 SHARES SOLD AT 118 PENCE

21 MARCH 2013, UK

15.

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

16.

Date issuer informed of transaction

142,246 SHARES

0.17%

21 MARCH 2013

 

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes

17

Date of grant

18.

Period during which or date on which it can be exercised

N/A

N/A

19.

Total amount paid (if any) for grant of the option

20.

Description of shares or debentures involved (class and number)

N/A

N/A

21.

Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

22.

Total number of shares or debentures over which options held following notification

N/A

N/A

23.

Any additional information

24.

Name of contact and telephone number for queries

INFORMATION IS BASED ON THE COMPANY'S CURRENT ISSUED SHARE CAPITAL WHICH IS 82,527,244

ANJUM O'NEILL, COMPANY SECRETARY, MICROGEN PLC: 020 7496 8100

 

 

 

Name and signature of duly authorised officer of issuer responsible for making notification

ANJUM O'NEILL, COMPANY SECRETARY, MICROGEN PLC

Date of notification: 21 MARCH 2013

www.microgen.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEFLFLXXFXBBB
Date   Source Headline
1st May 20244:10 pmRNSTotal Voting Rights
30th Apr 20244:46 pmRNSGrant of awards under 2020 Deferred Bonus Plan
29th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSNotice of 2024 Annual General Meeting
8th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20241:46 pmRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20247:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:01 amRNSAptitude to Accelerate Autonomous Finance
21st Mar 20247:01 amRNSShare buyback programme
21st Mar 20247:00 amRNSAudited Results for Year Ended 31 December 2023
21st Feb 20247:00 amRNSChange of Broker Arrangements
9th Feb 20247:00 amRNSHolding(s) in Company
31st Jan 20247:00 amRNSHolding(s) in Company
22nd Jan 20247:00 amRNSFull Year Trading Update and Notice of Results
4th Jan 20247:00 amRNSFynapse Win
30th Nov 20237:00 amRNSAppointment of Chief Executive Officer
12th Oct 20237:00 amRNSHolding(s) in Company
2nd Oct 20232:17 pmRNSGrant of awards
29th Sep 20237:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
21st Sep 20232:28 pmRNSHolding(s) in Company
20th Sep 20239:32 amRNSHolding(s) in Company
7th Sep 202310:15 amRNSGrant of Awards under Performance Share Plan
23rd Aug 20231:21 pmRNSHolding(s) in Company
23rd Aug 20231:15 pmRNSHolding(s) in Company
28th Jul 202312:18 pmRNSHolding(s) in Company
28th Jul 20237:00 amRNSHolding(s) in Company
27th Jul 20231:52 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSInterim Results
24th Jul 20235:22 pmRNSHolding(s) in Company
20th Jul 20237:00 amRNSHolding(s) in Company
19th Jul 20237:00 amRNSDirector Retirement
13th Jul 20237:00 amRNSTrading Update and Directorate Changes
23rd Jun 20234:43 pmRNSHolding(s) in Company
16th Jun 20234:22 pmRNSHolding(s) in Company
25th May 20235:22 pmRNSDirector/PDMR Shareholding
24th May 202311:01 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.